MARKET

XENE

XENE

Xenon Pharmaceut
NASDAQ
37.19
-0.06
-0.16%
After Hours: 37.14 -0.05 -0.13% 18:29 09/30 EDT
OPEN
37.38
PREV CLOSE
37.25
HIGH
37.53
LOW
36.71
VOLUME
2.47M
TURNOVER
--
52 WEEK HIGH
72.66
52 WEEK LOW
36.07
MARKET CAP
3.60B
P/E (TTM)
-7.8400
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XENE last week (0921-0925)?
Weekly Report · 2d ago
XENE Investors Have Opportunity to Join Xenon Pharmaceuticals Inc. Fraud Investigation with SBS Law
Barchart · 09/22 23:23
Xenon Pharmaceuticals Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Xenon Pharmaceuticals (XENE)
Barchart · 09/22 17:18
Analysts Conflicted on These Healthcare Names: Alcon (ALC), Xenon (XENE) and AnaptysBio (ANAB)
TipRanks · 09/22 12:50
Xenon Pharmaceuticals: Azetukalner Still Has Potential As An Epilepsy Candidate
Seeking Alpha · 09/22 12:14
Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
Barchart · 09/21 15:01
Weekly Report: what happened at XENE last week (0914-0918)?
Weekly Report · 09/21 09:23
J.P. Morgan Sticks to Its Buy Rating for Xenon (XENE)
TipRanks · 09/21 06:05
More
About XENE
Xenon Pharmaceuticals Inc. is a Canada-based neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing therapeutics to improve the lives of people living with neurological and psychiatric disorders. The Company is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the advanced, clinically validated potassium channel modulator in late-stage clinical development for the treatment of multiple indications that include epilepsy, including focal onset seizures (FOS), and primary generalized tonic-clonic seizures (PGTCS), as well as neuropsychiatric disorders including major depressive disorder (MDD), and bipolar depression (BPD). The Company is evaluating multiple therapeutic candidates targeting Kv7, Nav1.7, and Nav1.1 across various indications.

Webull offers Xenon Pharmaceuticals Inc stock information, including NASDAQ: XENE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XENE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XENE stock methods without spending real money on the virtual paper trading platform.